Enerox - Change of control approval
Source: Regulatory Document
The original document is the authoritative regulatory record.
RNS Number : 6646Y
Mustang Energy PLC
09 May 2023
9 May, 2023
Mustang Energy PLC
("MUST" or the "Company")
Approval from Austrian Federal Ministry of Labour and Economic Affairs
MUST is pleased to advise that it has received the approval of the Federal Ministry of Labour and
Economic Affairs of the Austrian Government regarding the proposed change of control of Enerox, as
more fully referred to in the 12 April 2023 announcement.
About Enerox
EHL is a special purpose vehicle which holds the entire issued share capital of Enerox, an Austrian-
based vanadium redox flow battery ("vrfb") manufacturer. Enerox has invested more than 20 years of
research and development into its energy storage system which is branded under the name CellCube.
Its vanadium-based technology is known to be state-of-the-art in the battery market and has already
deployed or is currently deploying more than 130 systems / 43 MWh across 5 continents. In the
preceding 12 months Enerox has announced 5 new orders for 34 MWh, which includes a 16 MWh
battery to an Australian based renewable project developer - Enerox's largest battery order to date.
CellCube designs and delivers sustainable and cost-effective energy storage solutions for microgrid
and grid scale-applications. The CellCube brand is a leader in an energy storage eco-system and has
developed a reputation for client service, system reliability and technical innovation. It has a stack and
system production capacity. It is focused on large commercial projects using the new generation FB
500-2000 technology.
ENQUIRIES
For further information, please visit www.mustangplc.com, follow us on Twitter
@Mustang_Plc, or contact:
Mustang Energy PLC
Dean Gallegos, Managing Director
dg@mustangplc.com
+61 416 220 007
This information is provided by RNS, the news service of the London Stock Exchange. RNS is
approved by the Financial Conduct Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For
further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how
you engage with the information contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services. For further information about how
RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy
Policy.